Table 7.
CEA (Original year of values) | Treatment vs. Comparator | ICER summary/estimate [2013 US$] | Unit of effectiveness | Incremental cost [2013 US$] | Incremental effectiveness |
---|---|---|---|---|---|
Augustin 1999 (1989) [22] | Hydrocolloid dressing vs. Vaseline gauze dressing | Dominant | Ulcer-free week gained | −3,362 | 1.3 |
DePalma 1999 (1998) [23] | Thera-boot vs. Unna’s boot | Dominant | Ulcer-free week gained | −601 | 1.71 |
Glinski 1999 (1998) [24] | Micronized purified flavonoid fraction + SC vs. SC alone | Dominanta | Additional wound healed | −714 | 0.19 |
Gordon 2006 (2005) [25] | Community leg club vs. community home nursing | 488a | Additional wound healed | Not reported | Not reported |
Guest 2012b (2010) [26] | NSBF vs. DBC | 18a | Percent additional reduction of ulcer area | 146 | 8 |
Guest 2012b (2010) [26] | NSBF vs. no skin protectant | 1a | Percent additional reduction of ulcer area | 17 | 22 |
Guest 2012b (2010) [26] | DBC vs. no skin protectant | Dominanta | Percent additional reduction of ulcer area | −129 | 14 |
Iglesias 2006 (2004) [27] | Pentoxifylline plus compression vs. placebo plus compression | Dominanta | QALY gained | −213 | 0.01 |
Iglesias 2004 (2001) [28] | Four-layer bandage vs. short-stretch bandage | Dominanta | QALY gained | −566 | 0.02 |
Jull 2008 (2005) [29] | Manuka honey dressing vs. UC | Dominanta,c | Additional wound healed | −48 | 0.06 |
Junger 2008 (2007) [30] | Low-frequency pulsed current (Dermapulse) vs. placebo | More costly & more effectived | Percent additional reduction of ulcer area | Not reported | Not reported |
Kerstein 2000b (1995) [31] | Hydrocolloid dressing plus compression hosiery vs. Unna’s boot | Dominant | Additional wound healed | −6,748 | 0.18 |
Kerstein 2000b (1995) [31] | Unna’s boot vs. saline gauze plus compression hosiery | More costly & more effectived | Additional wound healed | Not reported | Not reported |
Kikta 1988 (1987) [32] | Unna’s boot vs. hydrocolloid (DuoDERM) | Dominanta | Additional wound healed | −209 | 0.32 |
Michaels 2009 (2007) [33] | Antimicrobial silver-donating dressings vs. low-adherent dressings | 917,298a | QALY gained | 183 | 0.0002 |
Morrell 1998 (1995) [34] | Community leg ulcer clinics using four-layer compression bandaging vs. home nursing UC | 7a | Ulcer-free week gained | 44 | 5.9 |
O’Brien 2003 (2000) [35] | Four-layer bandage vs. UC | Dominanta | Increase in healing rate | −42 | 0.2 |
Oien 2001 (1997) [36] | Pinch grafting in primary care vs. pinch grafting in hospital | Cost saving & same effectiveness | Additional wound healed | −14,075 | 0 |
Sibbald 2001 (1997) [37] | Skin substitute (Apligraf) plus four-layer bandage vs. four-layer bandage only | 6095a | Additional wound healed | 457 | 0.075 |
Taylor 1998 (1987) [38] | Four-layer high-compression bandaging vs. UC | Dominanta | Additional wound healed | −659 | 0.095 |
Ukat 2003 (2002) [39] | Multilayer elastic bandaging (Profore) vs. short-stretch bandaging | Dominanta | Additional wound healed | −1,198 | 0.08 |
Watson 2011 (2007) [40] | Ultrasound plus SC vs. SC alone | Dominateda | QALY gained | 371 | −0.009 |
Pham 2012 (2009) [41] | Four-layer bandaging vs. short-stretch bandaging | 43,918a | QALY gained | 395 | 0.009 |
Schonfeld 2000 (1996) [42] | Apligraf (Graftskin) vs. Unna’s Boot | Dominanta | Ulcer-free month gained | −13,883 | 2.85 |
Simon 1996 (1993) [43] | Community leg ulcer clinic vs. UC clinic | Dominant | Additional wound healed | −1,826 | 0.22 |
Carr 1999 (1998) [44] | Four-layer compression bandaging (Profore) vs. UC | Dominanta | Additional wound healed | −1,289 | 0.13 |
Guest 2009 (2007) [45] | Amelogenin plus compression therapy vs. compression therapy only | Dominanta | QALY gained | −835 | 0.054 |
DBC, Durable barrier cream; ICER, Incremental cost-effectiveness ratio; NSBF, No sting barrier film; QALY, Quality-adjusted life-year; SC, Standard care; UC, Usual care; US$, United States dollars.
aDenotes the higher quality studies (Drummond score ≥8).
bMultiple comparisons are reported.
cICER was mostly due to an extra 3 patients hospitalized in control group… “probably due to random variation”. If remove these costs, the dominance is reversed in favor of UC.
dUnable to calculate specific ICER for these 2 studies because the data was not reported for all treatment arms or presented in a figure only but the overall result (more costly & more effective) was reported.